Summit Pharmaceuticals International

Every human being hosts between 10 trillion and 100 trillion symbiotic micro-organisms, including bacteria, viruses and archaea. The collective genomes of these micro-organisms form what is known as t

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy transactions that occurred between Oct. 1-10. Deal Watc

The November 2011 collaboration between Otsuka Pharmaceutical Co. Ltd. and Lundbeck Inc. involving central nervous system candidates from both companies was and remains an outlier when reviewi

Mergers & Acquisitions /In Vitro Diagnostics Clovis Oncology Inc. Roche Roche Diagnostics Roche Molecular Systems Inc. On the same day it received rights to a solid tumor compound from Pfizer Inc.